CJC-1295 + Ipamorelin

CJC-1295, a long-acting GHRH analog, is typically stacked with ipamorelin, a selective ghrelin-receptor agonist and GH secretagogue, to produce a stronger, still-pulsatile growth-hormone release than either compound alone.

The stacked combination is widely used in peptide-therapy clinics but lacks dedicated combination-specific outcome trials, and whether it meaningfully outperforms either compound alone for longevity-relevant body-composition outcomes in healthy adults has not been directly trialed. It is also marketed as a settled, readily-accessible stack — a framing that overstates how established it is.